
SUPN Technical Analysis Summary (NASDAQ)
Analyze SUPN on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerSUPN Technical Analysis Summary (NASDAQ)
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) stock currently shows a bullish trend on the NASDAQ, supported by momentum and strong buying pressure.
Technical conditions suggest Supernus Pharmaceuticals, Inc. on the NASDAQ is awaiting a decisive move. Overall, Supernus Pharmaceuticals, Inc. remains neutral, with indicators showing mixed momentum.
RSI (14): 54.26
Stochastic %K: 46.98
Williams %R: -47.11
Rate of Change (ROC): 1.40
Takeaway:Supernus Pharmaceuticals, Inc. shows neutral momentum, with indicators pointing to indecision.
MACD: 0.02
ADX: 23.68
ATR (14): 2.14
CCI (14): 57.56
Takeaway:Supernus Pharmaceuticals, Inc. shows strong upward trend with solid momentum and healthy volatility.
Takeaway:Supernus Pharmaceuticals, Inc. trades around the middle band, reflecting balanced price action.
Takeaway:Supernus Pharmaceuticals, Inc. trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:SUPN shows balanced money flow with a slight bullish bias.
Bullish Signals
RSI above 50 → positive momentum from buyers.
MACD above 0 → bullish trend confirmation.
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for Supernus Pharmaceuticals, Inc. are mixed, suggesting a Hold or wait-and-see approach.